Each senior member has over 30 years experience in their field of medicine, chemistry or period products.

The Team

Founder

JAB_14.jpg
Dr Tony Bairstow MB ChB
Director Aritex Ltd
Qualified Leeds Medical School 1981

Background

Dr Tony Bairstow has over 30 years clinical experience as a senior partner in medical practice. As founder and director of Aritex Biotech, work was started into developing improved designs in period products. Advances in biocompatibility of materials, combined with improved understanding of the physiological host responses, opened up new design possibilities for tampons, and a new design was launched

A UK patent was granted in 2022, followed by Europe and the US in 2024.

 

Team Members

JAB_14.jpg
Kyra Sharma
Biotechnologist
University of Leeds

Background

Kyra Sharma at the University of Leeds is working with Aritex to understand the implications of biomaterials on human health and improve our understanding of our initial target market.

 

JAB_14.jpg
Shane Dhiman
Bioscience Technology
MSc Bioscience, University of Leeds

Background

Shane Dhiman is an MSc Bioscience graduate from the University of Leeds, with a BSc in Biotechnology. He has expertise in biomaterial science and immunology research, combining academic rigour with a commitment to making a meaningful difference. Shane's multifaceted approach to academic excellence and community engagement makes him an invaluable asset to the Toruso project.

 

JAB_14.jpg
Lesley Sutherland
Commercial Strategist

Background

Lesley Sutherland is Aritex Biotech's commercial strategist, advising on growth, investment and scale-up strategy. A senior executive with experience across the UK, USA, Europe and Asia Pacific, Lesley has guided life sciences and biotechnology teams from 5 to over 180 staff, and prepared due diligence packages behind successful acquisitions and $50M+ funding rounds. Lesley also mentors founders and invests as an angel in Scotland's start-up ecosystem.

 

JAB_14.jpg
Ben Westerby
Financial Director
Westerby Consulting

Background

Ben Westerby is Aritex Biotech's fractional Finance Director, providing financial advice and strategic oversight. A CIMA-qualified accountant and ILM Level 7 coach, Ben has more than twenty years' experience in finance, including Finance Director roles before founding Westerby Consultancy, which supports growing businesses across a wide range of sectors. At Aritex Biotech, he advises on forecasting, financial planning and reporting, helping the leadership team make confident, well-informed decisions as the company grows.

 

JAB_14.jpg
Pamela Windle
Menstruation advisor
BSc Psychology and Sports Science

Background

Pamela Windle is a certified menstruation and menopause consultant for the workplace, with over 20 years of experience. She holds membership with the International Menopause Society and with the British Standards Institute as an advisor. Pamela also holds a BSc in Psychology and Sports Science and is advising Aritex Biotech on menstruators' experience and needs.

 

Advisory Board

JAB_14.jpg
Prof Steven Abbott PhD
Director at Steven Abbott TCNF Ltd
PhD in Chemistry from his work in Oxford and Harvard

Background

Professor Steven Abbott received his Ph.D. in chemistry from work at Oxford and Harvard before a post-doc with Nobel Prize winner Jean-Marie Lehn. He spent 30 years in the industry, first with the large UK chemical company ICI then as Research Director of a high-tech coatings company near Oxford. Prof. Abbott is a visiting professor at the School of Mechanical Engineering at the University of Leeds and director of Steven Abbott TCNF Ltd.

He is advising Aritex Biotech on elastomeric polymers and adhesion principles.

 

JAB_14.jpg
John F Poccia III
Poccia Consulting LLC
Associate Director Johnson & Johnson 1982 - 2019

Background

John Poccia III has over 30 patents in fields ranging from hygiene, medical devices, skincare, wound management, and baby/adult wipes. At Johnson & Johnson he worked with nonwovens to integrate superabsorbent monomers/polymers into a through air-bonded nonwoven with pulp fibers for use in a novel super thin diaper absorbent core. After working on baby diapers, he moved on to Personal Products Company in 1986, the feminine hygiene division of Johnson & Johnson. In 2000, he moved on to a newly created role Associate Director of External Alliances and Innovation and led a global team charged with developing a new way of bringing in innovation from outside of Johnson & Johnson.

He is advising Aritex Biotech on superabsorbent biomaterials, tampon prototype iteration and product development.

Important legal information

Registered in England and Wales no. 04510270
Use of this website is governed by our privacy policy, cookie policy and terms of use.